Sharon Giordano

Dr. Sharon Giordano from MD Anderson Cancer Center shares her insights on the latest updates for using abemaciclib with endocrine therapy in high-risk early breast cancer. She discusses key findings from the MonarchE trial, highlighting its effectiveness in improving disease-free survival. The conversation touches on the updated guidelines for patient eligibility and the critical balance between treatment benefits and potential risks. Giordano emphasizes the need for tailored approaches in clinical practice to enhance patient outcomes.